Biomarker Validation

Technological, Clinical and Commercial Aspects

Biomarker Validation

Technological, Clinical and Commercial Aspects

€120.99*

available, immediately via download

If you require delivery outside DE, AT or CH, please use our contact form for an inquiry.

From the Contents:

Biomarkers Past and Future

Quantitative Proteomics Techniques in Biomarker Discovery
Biomarker Qualification: A Company Point of View
Biomarker Discovery and Medical Diagnostic Imaging
Breath: An Often Overlooked Medium in Biomarker Discovery
HTA in Personalized Medicine Technologies
Bone Remodeling Biomarkers: New Actors on the Old Cardiovascular Stage
Identification and Validation of Breast Cancer Biomarkers
Evaluation of Proteomic Data: From Profiling to Network Analysis by Way of Biomarker Discovery
Biomarkers: From Discovery to Commercialization
Clinical Validation
Genomics and Proteomics for Biomarker Validation

For Biochemists, Clinical Chemists, Oncologists, Laboratory Medics, and Analytical Research Institutes.



Harald Seitz studied Biochemistry at the Free University of Berlin, accomplished his PhD working at the MPI for Molecular Genetics in 2000 and finished his habilitation at the University of Kassel in 2012. After working for nearly 10 years at the MPI for Molecular Genetics he moved to the Fraunhofer Institute for Biomedical Engineering in 2011. The focus of his work is on high throughput techniques especially all kinds of protein and peptide microarrays and in vitro diagnostics.

Sarah Schumacher studied Biology at the Free University of Berlin and completed her M.Sc. at the Humboldt University of Berlin. Before she started her PhD in 2013, she worked at the MPI for Molecular Genetics in Berlin and moved to the Fraunhofer IBMT in Potsdam-Golm in 2011. Her research interest is on biomarker and antibody validation.
ISBN 9783527680672
Article number 9783527680672
Media type eBook - ePUB
Copyright year 2015
Publisher Wiley-VCH
Length 400 pages
Language English
Copy protection Adobe DRM